Literature DB >> 17320906

Immunophenotypes in the circulation of patients with mild cognitive impairment.

Shino Magaki1, Steven M Yellon, Claudius Mueller, Wolff M Kirsch.   

Abstract

Alterations in the peripheral immune system are associated with dementia and the neuropathology of Alzheimer's disease, but have yet to be studied early in the disease process. To test the hypothesis that the balance of immune cell phenotypes is disrupted in the early progression of memory deterioration, patients with mild cognitive impairment (MCI) and healthy elderly controls were examined for the distribution of subpopulations of leukocytes (lymphocytes, granulocytes, and monocytes) and lymphocyte subtypes (helper/inducer and suppressor/cytotoxic T lymphocytes and B lymphocytes) in blood. MCI subjects had a significantly higher percentage of total lymphocytes and a lower percentage of granulocytes compared to elderly controls. Furthermore, the expression of cell surface amyloid precursor protein (APP) and intracellular amyloid-beta peptide (Abeta) in lymphocytes and monocytes were determined. We found lymphocyte APP expression to be significantly increased in MCI subjects compared to controls. Our data indicate that changes in immunological parameters may be detected early in MCI, and an alteration of the immune response may precede clinical AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320906      PMCID: PMC2167624          DOI: 10.1016/j.jpsychires.2007.01.004

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  39 in total

Review 1.  Cardiac risk factors and potential treatments in Alzheimer's disease.

Authors:  Christine Bergmann; Mary Sano
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

Review 2.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

3.  Enhanced production of amyloid precursor protein mRNA by peripheral mononuclear blood cell in Alzheimer's disease.

Authors:  Sanduo Jiang; Mingyuan Zhang; Daming Ren; Guomei Tang; Sicui Lin; Yiping Qian; Ye Zhang; Kaida Jiang; Fei Li; Dongxiang Wang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-04-01       Impact factor: 3.568

4.  Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease.

Authors:  Carla Scali; Costanza Prosperi; Laura Bracco; Carolina Piccini; Roberto Baronti; Andrea Ginestroni; Sandro Sorbi; Giancarlo Pepeu; Fiorella Casamenti
Journal:  Neurobiol Aging       Date:  2002 Jul-Aug       Impact factor: 4.673

5.  Immune system-associated antigens on the surface of peripheral blood lymphocytes in patients with Alzheimer's disease.

Authors:  T Ikeda; K Yamamoto; K Takahashi; M Yamada
Journal:  Acta Psychiatr Scand       Date:  1991-06       Impact factor: 6.392

6.  The decrease of CD8-positive lymphocytes in Alzheimer's disease.

Authors:  T Pirttilä; S Mattinen; H Frey
Journal:  J Neurol Sci       Date:  1992-02       Impact factor: 3.181

7.  Immune system response in Alzheimer's disease.

Authors:  P L McGeer; H Akiyama; S Itagaki; E G McGeer
Journal:  Can J Neurol Sci       Date:  1989-11       Impact factor: 2.104

Review 8.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

9.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

Authors:  Michael Grundman; Ronald C Petersen; Steven H Ferris; Ronald G Thomas; Paul S Aisen; David A Bennett; Norman L Foster; Clifford R Jack; Douglas R Galasko; Rachelle Doody; Jeffrey Kaye; Mary Sano; Richard Mohs; Serge Gauthier; Hyun T Kim; Shelia Jin; Arlan N Schultz; Kimberly Schafer; Ruth Mulnard; Christopher H van Dyck; Jacobo Mintzer; Edward Y Zamrini; Deborah Cahn-Weiner; Leon J Thal
Journal:  Arch Neurol       Date:  2004-01

10.  Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells.

Authors:  J S Allen; G M Murphy; L F Eng; K E Stultz; H D Davies; L B Pickford; J R Tinklenberg
Journal:  Neurosci Lett       Date:  1991-10-28       Impact factor: 3.046

View more
  6 in total

1.  Microglial TNF-α-dependent elevation of MHC class I expression on brain endothelium induced by amyloid-beta promotes T cell transendothelial migration.

Authors:  Yi-Ming Yang; De-Shu Shang; Wei-Dong Zhao; Wen-Gang Fang; Yu-Hua Chen
Journal:  Neurochem Res       Date:  2013-08-29       Impact factor: 3.996

Review 2.  Iron and the immune system.

Authors:  Roberta J Ward; Robert R Crichton; Deanna L Taylor; Laura Della Corte; Surjit K Srai; David T Dexter
Journal:  J Neural Transm (Vienna)       Date:  2010-09-29       Impact factor: 3.575

3.  Peripheral leukocyte populations and oxidative stress biomarkers in aged dogs showing impaired cognitive abilities.

Authors:  Paolo Mongillo; Daniela Bertotto; Elisa Pitteri; Annalisa Stefani; Lieta Marinelli; Gianfranco Gabai
Journal:  Age (Dordr)       Date:  2015-04-24

Review 4.  Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Authors:  Anna Morozova; Yana Zorkina; Olga Abramova; Olga Pavlova; Konstantin Pavlov; Kristina Soloveva; Maria Volkova; Polina Alekseeva; Alisa Andryshchenko; Georgiy Kostyuk; Olga Gurina; Vladimir Chekhonin
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 5.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

6.  Cognitive impairment is related to a reduced count of T-lymphocytes in older patients diagnosed with non-small cell lung cancer (NSCLC).

Authors:  Teresa Soria-Comes; Vicente Palomar-Abril; María Martín Ureste; Javier García Sánchez; Josefa Esperanza Marco Buades; María José Fernández Llavador; Amparo López Gabaldón; Mar González Jurado; Inmaculada Concepción Maestu Maiques
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.